1. Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis.;Berenbrok;J Am Pharm Assoc (Wash DC),2022
2. The U.S. Federal Retail Pharmacy Program: optimizing COVID-19 vaccine delivery through a strategic public-private partnership.;Kim;Public Health Rep,2023
3. CDC. Interim clinical considerations for use of COVID-19 vaccines: appendices, references, and previous updates. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. Accessed February 12, 2024. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us-appendix.html#appendix-a
4. Schorpp S, Calhoun K, Razzaghi H, Black CL. Concerns about bivalent COVID-19 vaccine and reasons for non-vaccination among adults who completed a primary series—Omnibus Survey, March 10–April 30, 2023 & Household Pulse Survey, March 1–April 10, 2023. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/pubs-resources/covid-vaccine-reasons-non-vaccination.html
5. Srivastav A, Williams WW, Santibanez TA, National early-season flu vaccination coverage, United States, November 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2017.htm